Publications by authors named "Susil Joe Isaac"
Pathol Oncol Res
July 2024
Article Synopsis
- * This review highlights the potential of immune checkpoint inhibitors (ICIs) used in both early-stage and metastatic NSCLC, suggesting benefits in perioperative settings.
- * Notably, the introduction of adjuvant atezolizumab and pembrolizumab has marked a breakthrough in treatment, improving disease-free survival and overall outcomes, especially when combined with chemotherapy in metastatic cases.
